These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 8311369)

  • 1. gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia.
    Nisticò A; Young NS
    Ann Intern Med; 1994 Mar; 120(6):463-9. PubMed ID: 8311369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia.
    Nakao S; Yamaguchi M; Shiobara S; Yokoi T; Miyawaki T; Taniguchi T; Matsuda T
    Blood; 1992 May; 79(10):2532-5. PubMed ID: 1586705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
    Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
    Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of Th1 cell in the pathogenesis of aplastic anemia].
    He H; Shao Z; He G; Liu H; Shi J; Fu R; Zhao M; Bai J; Jia H; Sun J; Cui Z; Chu Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):574-7. PubMed ID: 12482340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating activated suppressor T lymphocytes in aplastic anemia.
    Zoumbos NC; Gascón P; Djeu JY; Trost SR; Young NS
    N Engl J Med; 1985 Jan; 312(5):257-65. PubMed ID: 2981406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of vascular endothelial growth factor in patients with aplastic anemia and its significance].
    Ji JL; Liu H; Sun C; Jiang SH; Ding RS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):285-8. PubMed ID: 16638198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia.
    Schultz JC; Shahidi NT
    Am J Hematol; 1994 Jan; 45(1):32-8. PubMed ID: 8250009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.
    Feng X; Lin Z; Sun W; Hollinger MK; Desierto MJ; Keyvanfar K; Malide D; Muranski P; Chen J; Young NS
    Haematologica; 2017 Oct; 102(10):1691-1703. PubMed ID: 28729300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.
    Zoumbos NC; Gascon P; Djeu JY; Young NS
    Proc Natl Acad Sci U S A; 1985 Jan; 82(1):188-92. PubMed ID: 3918301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
    Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
    Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune aspects of aplastic anemia.
    Baranski BG; Young NS
    In Vivo; 1988; 2(1):91-4. PubMed ID: 2979824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the interferon-gamma single nucleotide polymorphism +874(T/A) with response to immunosuppressive therapy in patients with severe aplastic anemia.
    Chang H; Zeng F; Zhang JY; Mu XY; Meng WT; Ma HB; Liu T
    Blood Cells Mol Dis; 2010 Dec; 45(4):313-6. PubMed ID: 20934357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired aplastic anemia.
    Young NS
    Ann Intern Med; 2002 Apr; 136(7):534-46. PubMed ID: 11926789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.
    Sloand E; Kim S; Maciejewski JP; Tisdale J; Follmann D; Young NS
    Blood; 2002 Aug; 100(4):1185-91. PubMed ID: 12149196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.
    Bueno C; Roldan M; Anguita E; Romero-Moya D; Martín-Antonio B; Rosu-Myles M; del Cañizo C; Campos F; García R; Gómez-Casares M; Fuster JL; Jurado M; Delgado M; Menendez P
    Haematologica; 2014 Jul; 99(7):1168-75. PubMed ID: 24727813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased T cell immunoglobulin mucin-3 and its ligand in acquired aplastic anemia.
    Zhang J; Gu Y; Xu C; Qu X
    Eur J Haematol; 2008 Aug; 81(2):130-9. PubMed ID: 18485114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic and microenvironmental alterations in bone marrow associated with ROS in experimental aplastic anemia.
    Chatterjee R; Law S
    Eur J Cell Biol; 2018 Jan; 97(1):32-43. PubMed ID: 29173808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.
    Găman A; Găman G; Bold A
    Rom J Morphol Embryol; 2009; 50(4):669-74. PubMed ID: 19942964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.